Man Group’s Sage Therapeutics SAGE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-62,900
| Closed | -$342K | – | 2091 |
|
2024
Q4 | $342K | Buy |
+62,900
| New | +$342K | ﹤0.01% | 1610 |
|
2024
Q3 | – | Sell |
-25,903
| Closed | -$281K | – | 2028 |
|
2024
Q2 | $281K | Buy |
+25,903
| New | +$281K | ﹤0.01% | 1663 |
|
2023
Q3 | – | Sell |
-80,661
| Closed | -$3.79M | – | 2056 |
|
2023
Q2 | $3.79M | Buy |
+80,661
| New | +$3.79M | 0.01% | 967 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 917 |
|
2022
Q4 | – | Sell |
-9,053
| Closed | -$355K | – | 2163 |
|
2022
Q3 | $355K | Buy |
+9,053
| New | +$355K | ﹤0.01% | 1585 |
|
2022
Q2 | – | Sell |
-79,208
| Closed | -$2.62M | – | 948 |
|
2022
Q1 | $2.62M | Buy |
+79,208
| New | +$2.62M | 0.01% | 1131 |
|
2021
Q4 | – | Sell |
-4,603
| Closed | -$204K | – | 1975 |
|
2021
Q3 | $204K | Buy |
4,603
+1,095
| +31% | +$48.5K | ﹤0.01% | 1735 |
|
2021
Q2 | $200K | Sell |
3,508
-11,710
| -77% | -$668K | ﹤0.01% | 1793 |
|
2021
Q1 | $1.14M | Sell |
15,218
-33,714
| -69% | -$2.52M | 0.01% | 1258 |
|
2020
Q4 | $4.23M | Sell |
48,932
-79,555
| -62% | -$6.88M | 0.02% | 901 |
|
2020
Q3 | $7.85M | Buy |
128,487
+64,594
| +101% | +$3.95M | 0.03% | 580 |
|
2020
Q2 | $2.66M | Buy |
63,893
+26,577
| +71% | +$1.11M | 0.01% | 943 |
|
2020
Q1 | $1.07M | Buy |
+37,316
| New | +$1.07M | 0.01% | 1095 |
|
2019
Q4 | – | Sell |
-16,279
| Closed | -$2.28M | – | 1890 |
|
2019
Q3 | $2.28M | Buy |
16,279
+14,111
| +651% | +$1.98M | 0.01% | 1196 |
|
2019
Q2 | $397K | Sell |
2,168
-11,047
| -84% | -$2.02M | ﹤0.01% | 1704 |
|
2019
Q1 | $2.1M | Buy |
+13,215
| New | +$2.1M | 0.01% | 1306 |
|
2018
Q4 | – | Sell |
-15,452
| Closed | -$2.18M | – | 2077 |
|
2018
Q3 | $2.18M | Buy |
15,452
+10,848
| +236% | +$1.53M | 0.01% | 1376 |
|
2018
Q2 | $721K | Buy |
4,604
+3,205
| +229% | +$502K | ﹤0.01% | 1689 |
|
2018
Q1 | $225K | Buy |
+1,399
| New | +$225K | ﹤0.01% | 1881 |
|